发明名称 |
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS |
摘要 |
Disclosed are synthetic nanocarrier compositions, and related methods, comprising therapeutic protein APC presentable antigens and immunosuppressants that provide tolerogenic immune responses specific to therapeutic proteins. |
申请公布号 |
US2016220501(A1) |
申请公布日期 |
2016.08.04 |
申请号 |
US201514613170 |
申请日期 |
2015.02.03 |
申请人 |
Selecta Biosciences, Inc. |
发明人 |
Fraser Christopher;Kishimoto Takashi Kei;Maldonado Roberto A. |
分类号 |
A61K9/51;A61K39/00;A61K31/436 |
主分类号 |
A61K9/51 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition having a special physical form, wherein:
(i) said special physical form comprises synthetic nanocarrier particulates; (ii) said synthetic particulates comprise a PLGA polymer; (iii) a first population of said synthetic particulates are coupled to immunosuppressants; and (iv) a second population of said synthetic particulates are coupled to therapeutic protein APC presentable antigens wherein a mean of a particle size distribution obtained using dynamic light scattering of the synthetic nanocarrier particulates of the first and/or second population is a diameter greater than 100 nm. |
地址 |
Watertown MA US |